Outcome of Cochlear Implant in Assiut University

Status Not yet recruiting

Clinical Trial Summary

Evaluation of the outcome of cochlear implanted children at audiovestibular medicine unit in Assiut university hospital.

Clinical Trial Description

Hearing loss is one of the most common health problems affecting people around the world with an average international incidence of 5% . In Egypt, it affects 16% of the population with an incidence of 14% in children less than 14 years old. 86% of deaf patients had conductive hearing loss (CHL), while sensorineural hearing loss (SNHL) was found in 14%, with a male to female ratio of 3:2 HL . Cochlear implantation (CI) has become a routine procedure in the United States and worldwide for the management of severe-to-profound SNHL loss. It is a remarkable example of success that was made possible through collaboration between engineers, surgeons, scientists and the medical community . Early cochlear implantation had a long-term positive impact on auditory and verbal development, if auditory stimulation does not occur within this timeframe, the auditory system degenerates. It has been suggested that in the absence of normal auditory stimulation there is a period of about 3.5 years during which the central auditory system retains its maximum plasticity. This can extend in some children up to the age of approximately 7 years, after which it is significantly reduced. The earlier implantation causes better outcomes, including improved language development, speech perception and speech production skills . Early research reviews found that the ability to communicate in spoken language was better the earlier the implantation was performed. These reviews also found that cochlear implants provide open set speech understanding for the majority of implanted profoundly hearing-impaired children, and that it was not possible to accurately predict the specific outcome of the given implanted child . Research since then has reported long-term socio-economic benefits for children as well as audiological outcomes including improved sound localization and speech perception . The outcome of CI surgery on Quality of Life (QoL) has been greatly investigated via parental questionnaire assessment. This questionnaire was designed with 11 subscales and 58 questions in total. All questions were scaled from 1 to 5: (1 strongly agree; 2 agree; 3 neither agree nor disagree; 4 disagree; and 5 strongly disagree) . ;

Study Design

Related Conditions & MeSH terms

Cochlear Implant

Clinical Trial Details

NCT number	NCT05275712
Study type	Observational
Source	Assiut University
Contact	Sally Shenouda Bolis, Master
Phone	+201552431299
Email	sallyshenouda1993@gmail.com
Status	Not yet recruiting
Phase
Start date	March 2023
Completion date	July 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04222296` - Bimodal, CROS and Severe Profound Hearing Loss Study	N/A
Completed	`NCT04577118` - The iotaSOFT Insertion System Safety Study	N/A
Withdrawn	`NCT04041596` - Degree of Benefit From Low-Frequency Acoustic Amplification Using the Advanced Bionics Acoustic Earhook	Phase 4
Completed	`NCT01737489` - Title: "Development and Implementation of Innovative Auditory Training Methods and Verification of These Training Methods"	N/A
Completed	`NCT03304106` - Clinical Investigation of New CI Delivery Models in an Adult Nucleus CI Population	N/A
Active, not recruiting	`NCT03685461` - AB-Intra- and Post-Operative Measures of Auditory Function	N/A
Completed	`NCT03515473` - Subjective and Objective Results With CI Electrode Types
Terminated	`NCT03025386` - Establish a Concordance Between the Mismatch Negativity Amplitude and a Score of Logatoms Discrimination	N/A
Completed	`NCT02966379` - Hearing Preservation and Electro-acoustic Stimulation With EVO® Electrode Lead and Zebra® Sound Processor	N/A
Completed	`NCT03202797` - Optimizing Regulation of a Cochlear Implant in Patients With Functional Contralateral Audition.
Recruiting	`NCT05360212` - Anatomy-based Fitting in Cochear Implant Users	N/A
Not yet recruiting	`NCT06142682` - Dexamethasone Eluting Cochlear Implant: a Pivotal Study	N/A
Recruiting	`NCT03886168` - Pediatric Image-Guided Cochlear Implant Programming	N/A
Enrolling by invitation	`NCT03306082` - Image-guided Cochlear Implant Programming (IGCIP)	N/A
Enrolling by invitation	`NCT04320251` - Tissue Growth Characterization for Cochlear Implant Users	N/A
Recruiting	`NCT05079867` - Cochlear Trauma, Functional and Structural Preservation in Cochlear Implant Surgery
Recruiting	`NCT06086041` - Predictive Study on Hearing Rehabilitation After Cochlear Implant
Active, not recruiting	`NCT04722042` - Place-based Mapping in EAS Listeners	N/A
Recruiting	`NCT04711538` - Role of Diagnostic Imaging in Cochlear Implant
Completed	`NCT01638052` - Great Auricular Nerve Block for Children Undergoing Tympanomastoid Surgery	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.